Visualitza per autor "Pietrantonio, Filippo"
Ara mostrant els elements 1-4 d 4
-
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
Petrelli, Annalisa; rizzolio, sabrina; Pietrantonio, Filippo; bellomo, sara erika; Benelli, Matteo; de cecco, loris; Llop-Guevara, Alba; Serra, Violeta (American Association for Cancer Research, 2023-05-15) -
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial
Manca, Paolo; Corso, Simona; Raimondi, Alessandra; Berrino, Enrico; Tabernero Caturla, Josep; Pietrantonio, Filippo; Bellomo, Sara Erika (American Association for Cancer Research, 2023-02-01) -
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Corti, Francesca; Infante, Gabriele; Elez Fernandez, Mª Elena; Ros Montañá, Fco. Javier; Fakih, Marwan; Pietrantonio, Filippo; Lonardi, Sara (BMJ, 2021-08) -
Practical considerations in the use of regorafenib in metastatic colorectal cancer
Antonuzzo, Lorenzo; Bachet, Jean-Baptiste; Kuan, Feng-Che; Macarulla Mercadé, Teresa; Loupakis, Fotios; Pietrantonio, Filippo (SAGE Publications, 2020-10-31)